Event Participants
Executives
7
Anand Balakrishnan, Joseph Anantharaju, Pravin Darshanker, Priyanka Sharma, Ram Mohan, Sridhar Mantha, Venkat Raman Narayanan
Analysts
5
Aditi Patil, Amit Chandra, Ganesh Valla, Kuber, Rajveer Singh
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Operating Revenue | ₹629 crores | +4% QoQ, +14.3% YoY in INR terms; constant currency +2.6% QoQ and +6.7% YoY |
| Total Income | ₹652 crores | +4.9% QoQ, +12.5% YoY |
| EBITDA Margin | 21.7% | As stated in CEO commentary; reflects continued investment in AI, platforms, talent, and go-to-market |
| Operating Margin (EBIT) | 17.5% of revenue (₹109 crores) | Flat QoQ/YoY in percentage terms; adjusted ~19.75% excluding ₹11 crores forex loss on forward contracts and ₹5 crores one-time provision for delayed receivables |
| Adjusted PAT | ₹80.5 crores | 12.3% of total income; +12.9% QoQ, +14.0% YoY; adjustments relate only to acquisition costs |
| Adjusted EPS | ₹34.5 | +30% YoY |
| ROCE / ROE | 23.9% / 15.5% | Improved from 21.8% / 12.8% in Q4 FY26 |
| Cash & Cash Equivalents | ₹1,743 crores | Up from ₹1,679 crores in Q4 FY26 |
| Active Customers | 306 | Flat QoQ |
| Billion-Dollar Customers | 92 | +1 QoQ; contribute ~60% of revenue |
| Repeat Business | 94.4% | Up from 92.2% (per management commentary) |
| Working Capital Days | 92 days | Improved from 94 days QoQ |
| Headcount | 6,530 | Net addition of +32 in the quarter |
| Utilization | 81% | Down 0.4% QoQ; management views as healthy but a focus area |
| Voluntary Attrition | 15.4% | Improved from 17% in Q4 FY26 |
Geographic & Segment Commentary
- BFSI: Remained the largest vertical at 27% of revenues.
- Healthcare & Life Sciences: Fastest-growing vertical, up 22% YoY and 4% sequentially.
- EdTech: Contributed 16% of revenues with modest sequential growth; management believes the vertical has stabilized, supported by the EduWeave AI university platform with ~4 advanced conversations and 2 near signing.
- High Tech: Recorded strong sequential recovery (~10% QoQ) driven by a large engagement with an existing customer; a second large engagement is possible, but management cautioned this pace is not sustainable every quarter.
- Americas: Largest geography at 57% of revenues.
- India & APAC: Grew ~9% and ~10% sequentially respectively, reflecting broader geographic diversification; these markets create constant-currency headwinds as volume growth is divided by dollars.
Company-Specific & Strategic Commentary
- AI-First Strategy & Productivity Metrics: 100+ AI agents and ~60 repeatable use cases; 2,000+ employees using advanced agentic AI development tools generating 2.5M+ lines of code per month; ~60% of identified provisioning scope automated in infrastructure services with ~2x provisioning speed improvement; ~80% effort reduction in application integration.
- Enterprise Platforms Portfolio: Modular, model-agnostic enterprise AI platform designed for reuse; Arttha, Insurance-in-a-Box, Multanomics, Irubee, EduWeave AI, and SecAIGenie create differentiated customer entry points, enable nonlinear growth, and support larger transformation engagements.
- Generative AI Business Services (GBS): At ~5.5-6% of revenues; shifting from point use cases/fixed bids to PaaS-like external engineering teams and bundled AI + digital transformation deals; management plans to disclose company-wide AI-led revenue (beyond GBS, across all business units) with Q2 FY27 results.
- Sales Engine Restructuring: Segregating hybrid BDMs into net-new BDMs and account managers; 6-10 strategic accounts targeted for disproportionate attention with a goal of building them into $20 million accounts; repeat business improved to 94.4%.
- Notable Q1 Wins: Strategic data & AI partnership with a North American energy infrastructure company; AI-powered test automation for an Australian insurer; digital commerce modernization for an Indian MNC CPG company; Salesforce-based product engineering for a global consulting firm; multi-year managed security services with a Middle Eastern retailer.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| FY2027 Revenue Growth | 12.5% YoY | Reaffirmed after Q1; excludes new acquisitions (includes existing acquired entities); implies ~5% CQGR in remaining quarters, dependent on conversion of mid-to-large pipeline deals, Arttha deal closure expected in Q2, existing-account expansion, and lumpy India/Middle East/APAC revenue |
| FY2028 Revenue Aspiration | 15% growth | Maintained; management sees FY27 12.5% as the platform; contingent on macro stability, AI CapEx sentiment, and continued pipeline conversion |
| Q2 FY27 Margins | Wage increment impact expected | Annual increments for grades up to C7 in Q2 with C8+ in October; magnitude tempered in line with demand scenario; management highlighted ~19.75% real adjusted margin as a buffer |
| AI-Led Revenue Disclosure | Q2 FY27 results | Company-wide AI-led revenue (carved out across all BUs, not just GBS) to be published after internal validation |
Risks & Constraints
| Risk | Context |
|---|---|
| Geopolitical / War-Driven Inflation | Management flagged prolonged conflict as the "elephant in the room"; could extend selective discretionary spending and undermine sustained Q1-level performance |
| AI Sector CapEx Reality Check | Industry-wide reassessment of AI capital expenditure and spends could have trickle-down sentiment effects on client budgets; management is monitoring |
| Selective Discretionary Spending | Clients are using AI to optimize support/maintenance/infra activities and redeploying savings into AI/innovation; new discretionary commitments remain cautious |
| Constant-Currency Dilution | Growing revenue from India, Middle East, Southeast Asia, and APAC is divided by dollars in constant-currency metrics, understating volume growth relative to INR-based guidance |
| Arttha Deal Slippage | One banking deal extension is not expected to convert; a second is delayed with closure expected in Q2 - creates revenue lumpiness |
| Receivables Provision | ₹5 crores one-time provision booked in Q1 for delayed collections; management is being conservative and pursuing recovery of most of the amount |
| Q2 Wage Inflation | Annual compensation revisions will pressure Q2 FY27 margins; partially offset by real adjusted margins and volume/value growth |
Q&A Highlights
Revenue Guidance Attainability & Pipeline Visibility
- Question: With FY27 guidance implying ~5% CQGR for the remaining three quarters, what visibility exists - is it from won deals or pipeline conversion, how has TCV grown YoY, and does guidance include acquisitions? (Aditi Patil, ICICI Securities)
- Answer: Guidance excludes new acquisitions but includes entities already acquired. TCV is not disclosed since IPO; growth philosophy anchors on land-and-expand and customer cohort analysis (50% of revenue from customers with <5 year relationships). Pipeline is strong, up sequentially and significantly YoY; growth will come from converting mid-to-large deals (revenue from Q3/Q4), two three-digit TCV deals closed (one in Q1, one in early July 2026), existing-account expansion, and possible Arttha closure in Q2. Constant-currency is hurt by lumpy Middle East/India/Southeast Asia/APAC revenue divided by dollars. (Venkat Raman Narayanan; Joseph Anantharaju)
GenAI Business Model, Margins & AI-Led Revenue Disclosure
- Question: Are GenAI deals short-cycle with lesser recurring component, and what should be considered steady-state margins/investments for GBS? (Aditi Patil, ICICI Securities)
- Answer: Engagement model has shifted from point use cases to (1) PaaS-like external engineering teams for customers' AI journeys and (2) bundled AI + digital transformation deals - both driving longer-term engagements. T&M contracts now embed SLAs/outcomes, making them outcome-based in practice. GBS margins reflect improved utilization and cross-selling from other business units; GBS is targeted to reach at least ~10% of company revenue. Company plans to disclose company-wide AI-led revenue (not just GBS, e.g., SecAIGenie in security) with Q2 results. (Sridhar Mantha; Venkat Raman Narayanan)
Risks to FY27 Guidance & FY28 Aspiration
- Question: With cautious discretionary spending, what are the key risks to the 12.5% guidance, and does the FY28 15% aspiration still hold? (Ganesh Valla, HDFC Securities)
- Answer: Customers are optimizing support/maintenance/infra with AI and redeploying savings into AI and innovation; the key risk is prolonged geopolitical conflict driving inflation. FY28 15% aspiration is unchanged - FY27 12.5% sets the platform; management also noted a "reality check" in the AI world around CapEx with trickle-down sentiment effects. Deal sizes and business commitments in new sign-ups are improving, repeat business is up, and business restructuring into two BUs (PDES and Infra & Security) is working. (Joseph Anantharaju; Venkat Raman Narayanan)
EdTech & High Tech Vertical Outlook
- Question: Will EdTech sequential growth sustain, and how should the high-tech recovery be read? (Ganesh Valla, HDFC Securities)
- Answer: EdTech has stabilized; the EduWeave AI university platform (built from U.S. and Philippines customer experience) has ~4 advanced conversations with 2 near signing, and universities are a newly targeted segment. High Tech grew ~10% QoQ on a large engagement with an existing customer started months back; a second large engagement is possible and a newly signed customer should ramp, but this growth pace is not expected every quarter. (Joseph Anantharaju)
Fixed-Price Mix, BU Performance & Pricing Pressure
- Question: Is the company deliberately moving to fixed-price contracts, what drives faster growth in product/digital and GenAI units, and is there pricing pressure? (Kuber, Axis Securities)
- Answer: FP/T&M is a contract classification, not the business model - both buckets are outcome/output-based via detailed SOWs; management is exploring outcome-based pricing as a separate third bucket. GBS is growing handsomely off a small base with pull-through into PDES; IMSS sequential dip was due to a one-time Q4 license revenue that did not repeat - pipeline is strong and growth should resume next quarter. No systemic pricing pressure; rate increases were achieved with several customers, though customers increasingly ask to quantify the impact of AI tools in the SDLC. (Venkat Raman Narayanan; Joseph Anantharaju)
AI Productivity Monetization & Competitive Positioning
- Question: How do AI productivity gains translate into higher revenue rather than lower billing, and where is the sustainable edge versus TCS, Infosys, and Persistent? (Rajveer Singh, Vivek Investment Managers)
- Answer: In fixed-price projects, AI tools are embedded in estimates with upside shared between customer and company; in T&M, a ~40-person AI/SDLC CoE with AI champions drives adoption and generates additional revenue. Competitive edge comes from relative AI depth (classical AI work since 2013-14 in personalization, recommendations, adaptive learning), a digital-services foundation where AI is the "tip of the iceberg" over a digital base, and organizational agility (e.g., creating GBS) that scaled peers cannot match at similar focus. (Joseph Anantharaju; Sridhar Mantha)
GBS Scaling, AI Hiring & Sales Engine Payoff
- Question: How is GBS scaling (~5.5-6% of revenue) - is growth from existing clients, how much hiring is AI-specific, and what benefits are visible from sales engine/account mining investments? (Amit Chandra, HDFC Securities)
- Answer: GBS was set up ~1.5 years ago; POCs have migrated to sustained larger projects, with existing-client selling driving profitability. AI is embedded across all BUs - the company is carving out AI-led revenue across all revenue streams and will disclose by end of Q2. Hiring is split across replacement, future, and project-specific buckets; fresh/junior hiring is skewed toward AI skills plus heavy in-house AI-native training. Sales engine investments are paying off: a large high-tech deal started in April, another three-digit deal signed in July, repeat business improved to 94.4%, and the team is restructured into net-new BDMs and account managers with 6-10 accounts targeted for disproportionate attention and a $20 million account goal. (Venkat Raman Narayanan; Joseph Anantharaju)
Key Takeaway
Happiest Minds started FY2027 on a strong note with operating revenue of ₹629 crores (+14.3% YoY in INR; +6.7% YoY and +2.6% QoQ in constant currency), led by healthcare & life sciences (+22% YoY) and a high-tech recovery (~10% QoQ), with GBS at ~5.5-6% of revenue emerging as the primary incremental growth engine. Operating margin held at 17.5% (adjusted ~19.75%) despite ₹11 crores forex losses and ₹5 crores one-time receivables provisions, while ROCE improved to 23.9%, voluntary attrition fell to 15.4%, and cash stood at ₹1,743 crores. Management reaffirmed FY2027 guidance of 12.5% revenue growth, underpinned by a strong pipeline, two three-digit TCV deal closures, 100+ AI agents, proprietary platforms (Arttha, Insurance-in-a-Box, EduWeave AI), and a restructured sales engine focused on 6-10 strategic accounts. Watch points include Q2 wage-increment margin pressure, Arttha closure timing, constant-currency dilution from India/APAC-led growth, and geopolitical impacts on discretionary spending; the FY2028 15% growth aspiration remains intact contingent on macro stability and continued AI-led pipeline conversion.